ELV
insider transactionsElevance Health, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-2.3K
3.0K buy · 5.3K sell
Net value · 365d
-$875.2K
$869.5K in · $1.7M out
Sentiment · 365d
Net selling
33% buying · 67% selling
Open-market trades · 365d
6
3.0K buy · 5.3K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Sell·S
CAO & Controller
$148.8K
369 sh · $403.16
Own -9%
-
Sell·S
Director
$60.7K
151 sh · $401.77
Own -1%
-
Exercise·M
CAO & Controller
$0
877 sh
Own New
-
Exercise·M
CAO & Controller
$0
654 sh
Own New
-
Sell·S
CAO & Controller
$617.2K
1.5K sh · $403.13
Own -27%
-
Exercise·M
CAO & Controller
$273.2K
877 sh · $311.48
Own +18%
-
Exercise·M
CAO & Controller
$177.4K
654 sh · $271.27
Own +16%
-
Grant·A
Director
$0
563 sh
Own +12%
-
Grant·A
Director
$0
563 sh
Own +11%
-
Grant·A
Director
$0
563 sh
Own +34%
-
Grant·A
Director
$0
563 sh
Own +258%
-
Grant·A
Director
$0
563 sh
Own +9%
-
Grant·A
Director
$0
563 sh
Own +6%
-
Grant·A
Director
$0
563 sh
Own +5%
-
Grant·A
Director
$0
563 sh
Own +5%
-
Grant·A
Director
$0
563 sh
Own +15%
-
Sell·S
Director
$7.5K
26 sh · $287.50
Own -11%
-
Grant·A
Director
$0
2.7K sh
Own +28%
-
Sell·S
Charles Morgan Kendrick JR KEY
EVP & President, Commercial
$910.6K
3.2K sh · $284.92
Own -21%
-
Buy·P
Director
$869.5K
3.0K sh · $289.84
Own +469%
-
Other·F
EVP & Chief Legal Officer
$118.4K
417 sh · $284.03
Own -5%
-
Other·F
Charles Morgan Kendrick JR KEY
EVP & President, Commercial
$132.6K
467 sh · $284.03
Own -3%
-
Other·F
Mark Kaye KEY
EVP & CFO
$100.3K
353 sh · $284.03
Own -1%
-
Other·F
EVP &Chief Health Benefits Ofr
$140.9K
496 sh · $284.03
Own -1%
-
Other·F
EVP & Chief Digital Info Ofr
$63.1K
222 sh · $284.03
Own -1%
-
Other·F
CAO & Controller
$10.5K
37 sh · $284.03
Own -1%
-
Other·F
EVP & Pres Carelon & CarelonRx
$126.7K
446 sh · $284.03
Own -2%
-
Other·F
EVP & Chief HR Officer
$87.8K
309 sh · $284.03
Own -4%
-
Other·F
Gail Boudreaux KEY
President and CEO
$493.1K
1.7K sh · $284.03
Own -1%
-
Grant·A
EVP & Chief Legal Officer
$0
11.8K sh
Own New
-
Grant·A
EVP & Chief Legal Officer
$0
3.0K sh
Own +59%
-
Grant·A
Charles Morgan Kendrick JR KEY
EVP & President, Commercial
$0
15.9K sh
Own New
-
Grant·A
Charles Morgan Kendrick JR KEY
EVP & President, Commercial
$0
2.5K sh
Own +20%
-
Grant·A
Charles Morgan Kendrick JR KEY
EVP & President, Commercial
$0
4.0K sh
Own +45%
-
Other·F
Charles Morgan Kendrick JR KEY
EVP & President, Commercial
$356.1K
1.2K sh · $294.07
Own -12%
-
Grant·A
Mark Kaye KEY
EVP & CFO
$0
25.2K sh
Own New
-
Grant·A
Mark Kaye KEY
EVP & CFO
$0
10.2K sh
Own +46%
-
Grant·A
Mark Kaye KEY
EVP & CFO
$0
6.4K sh
Own +40%
-
Other·F
Mark Kaye KEY
EVP & CFO
$79.7K
271 sh · $294.07
Own -2%
-
Grant·A
EVP &Chief Health Benefits Ofr
$0
23.5K sh
Own New
-
Grant·A
EVP &Chief Health Benefits Ofr
$0
2.9K sh
Own +8%
-
Grant·A
EVP &Chief Health Benefits Ofr
$0
6.0K sh
Own +19%
-
Other·F
EVP &Chief Health Benefits Ofr
$417.9K
1.4K sh · $294.07
Own -4%
-
Grant·A
EVP & Chief Digital Info Ofr
$0
20.2K sh
Own New
-
Grant·A
EVP & Chief Digital Info Ofr
$0
6.8K sh
Own +71%
-
Grant·A
EVP & Chief Digital Info Ofr
$0
5.1K sh
Own +114%
-
Other·F
EVP & Chief Digital Info Ofr
$92.6K
315 sh · $294.07
Own -7%
-
Grant·A
CAO & Controller
$0
1.7K sh
Own New
-
Grant·A
CAO & Controller
$0
266 sh
Own +7%
-
Grant·A
CAO & Controller
$0
1.7K sh
Own +78%
-
Grant·A
CAO & Controller
$0
426 sh
Own +24%
-
Other·F
CAO & Controller
$38.5K
131 sh · $294.07
Own -7%
-
Grant·A
EVP & Pres Carelon & CarelonRx
$0
2.9K sh
Own +12%
-
Other·F
EVP & Pres Carelon & CarelonRx
$353.2K
1.2K sh · $294.07
Own -5%
-
Grant·A
EVP & Chief HR Officer
$0
11.8K sh
Own New
-
Grant·A
EVP & Chief HR Officer
$0
3.0K sh
Own +74%
-
Other·F
EVP & Chief HR Officer
$7.4K
25 sh · $294.07
Own -1%
-
Grant·A
Gail Boudreaux KEY
President and CEO
$0
63.8K sh
Own New
-
Grant·A
Gail Boudreaux KEY
President and CEO
$0
10.5K sh
Own +7%
-
Grant·A
Gail Boudreaux KEY
President and CEO
$0
16.2K sh
Own +11%
-
Other·F
Gail Boudreaux KEY
President and CEO
$2.0M
6.7K sh · $294.07
Own -4%
-
Grant·A
Director
$0
218 sh
Own New
-
Other·F
EVP & Chief HR Officer
$95.4K
279 sh · $341.83
Own -6%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 12, 2026 | Ronald W Penczek | Sell S | 369 | $148.8K |
| Jun 11, 2026 | Robert L Dixon JR | Sell S | 151 | $60.7K |
| May 19, 2026 | Ronald W Penczek | Exercise M | 877 | $0 |
| May 19, 2026 | Ronald W Penczek | Exercise M | 654 | $0 |
| May 19, 2026 | Ronald W Penczek | Sell S | 1.5K | $617.2K |
| May 19, 2026 | Ronald W Penczek | Exercise M | 877 | $273.2K |
| May 19, 2026 | Ronald W Penczek | Exercise M | 654 | $177.4K |
| May 13, 2026 | Bahija Jallal | Grant A | 563 | $0 |
| May 13, 2026 | Antonio F Neri | Grant A | 563 | $0 |
| May 13, 2026 | Deanna D Strable-Soethout | Grant A | 563 | $0 |
| May 13, 2026 | Amy W Schulman | Grant A | 563 | $0 |
| May 13, 2026 | Ryan M. Schneider | Grant A | 563 | $0 |
| May 13, 2026 | Ramiro G Peru | Grant A | 563 | $0 |
| May 13, 2026 | Lewis Hay III | Grant A | 563 | $0 |
| May 13, 2026 | Robert L Dixon JR | Grant A | 563 | $0 |
| May 13, 2026 | Steven H Collis | Grant A | 563 | $0 |
| Mar 12, 2026 | Amy W Schulman | Sell S | 26 | $7.5K |
| Mar 11, 2026 | Gail Boudreaux | Grant A | 2.7K | $0 |
| Mar 6, 2026 | Charles Morgan Kendrick JR KEY | Sell S | 3.2K | $910.6K |
| Mar 5, 2026 | Steven H Collis | Buy P | 3.0K | $869.5K |
| Mar 3, 2026 | Erin M Wessling | Other F | 417 | $118.4K |
| Mar 3, 2026 | Charles Morgan Kendrick JR KEY | Other F | 467 | $132.6K |
| Mar 3, 2026 | Mark Kaye KEY | Other F | 353 | $100.3K |
| Mar 3, 2026 | Felicia F Norwood | Other F | 496 | $140.9K |
| Mar 3, 2026 | Ratnakar Lavu | Other F | 222 | $63.1K |
| Mar 3, 2026 | Ronald W Penczek | Other F | 37 | $10.5K |
| Mar 3, 2026 | Peter D Haytaian | Other F | 446 | $126.7K |
| Mar 3, 2026 | Ryan R Craig | Other F | 309 | $87.8K |
| Mar 3, 2026 | Gail Boudreaux KEY | Other F | 1.7K | $493.1K |
| Mar 2, 2026 | Erin M Wessling | Grant A | 11.8K | $0 |
| Mar 2, 2026 | Erin M Wessling | Grant A | 3.0K | $0 |
| Mar 2, 2026 | Charles Morgan Kendrick JR KEY | Grant A | 15.9K | $0 |
| Mar 2, 2026 | Charles Morgan Kendrick JR KEY | Grant A | 2.5K | $0 |
| Mar 2, 2026 | Charles Morgan Kendrick JR KEY | Grant A | 4.0K | $0 |
| Mar 2, 2026 | Charles Morgan Kendrick JR KEY | Other F | 1.2K | $356.1K |
| Mar 2, 2026 | Mark Kaye KEY | Grant A | 25.2K | $0 |
| Mar 2, 2026 | Mark Kaye KEY | Grant A | 10.2K | $0 |
| Mar 2, 2026 | Mark Kaye KEY | Grant A | 6.4K | $0 |
| Mar 2, 2026 | Mark Kaye KEY | Other F | 271 | $79.7K |
| Mar 2, 2026 | Felicia F Norwood | Grant A | 23.5K | $0 |
| Mar 2, 2026 | Felicia F Norwood | Grant A | 2.9K | $0 |
| Mar 2, 2026 | Felicia F Norwood | Grant A | 6.0K | $0 |
| Mar 2, 2026 | Felicia F Norwood | Other F | 1.4K | $417.9K |
| Mar 2, 2026 | Ratnakar Lavu | Grant A | 20.2K | $0 |
| Mar 2, 2026 | Ratnakar Lavu | Grant A | 6.8K | $0 |
| Mar 2, 2026 | Ratnakar Lavu | Grant A | 5.1K | $0 |
| Mar 2, 2026 | Ratnakar Lavu | Other F | 315 | $92.6K |
| Mar 2, 2026 | Ronald W Penczek | Grant A | 1.7K | $0 |
| Mar 2, 2026 | Ronald W Penczek | Grant A | 266 | $0 |
| Mar 2, 2026 | Ronald W Penczek | Grant A | 1.7K | $0 |
| Mar 2, 2026 | Ronald W Penczek | Grant A | 426 | $0 |
| Mar 2, 2026 | Ronald W Penczek | Other F | 131 | $38.5K |
| Mar 2, 2026 | Peter D Haytaian | Grant A | 2.9K | $0 |
| Mar 2, 2026 | Peter D Haytaian | Other F | 1.2K | $353.2K |
| Mar 2, 2026 | Ryan R Craig | Grant A | 11.8K | $0 |
| Mar 2, 2026 | Ryan R Craig | Grant A | 3.0K | $0 |
| Mar 2, 2026 | Ryan R Craig | Other F | 25 | $7.4K |
| Mar 2, 2026 | Gail Boudreaux KEY | Grant A | 63.8K | $0 |
| Mar 2, 2026 | Gail Boudreaux KEY | Grant A | 10.5K | $0 |
| Mar 2, 2026 | Gail Boudreaux KEY | Grant A | 16.2K | $0 |
| Mar 2, 2026 | Gail Boudreaux KEY | Other F | 6.7K | $2.0M |
| Feb 2, 2026 | Amy W Schulman | Grant A | 218 | $0 |
| Feb 2, 2026 | Ryan R Craig | Other F | 279 | $95.4K |
About ELV insider trading
This page tracks insider transactions for Elevance Health, Inc. (ELV) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.